TRDA insider transaction filings
Entrada Therapeutics, Inc. — 47 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-10. Screen TRDA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | PARMAR KUSH — Director | Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85 · Sale (S): 92,444 @ $7 | EDGAR |
| 2026-08-10 | 4 | 5AM Ventures V, L.P. — 10% owner 5AM Partners V, LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85 | EDGAR |
| 2026-08-03 | 4 | 5AM Ventures V, L.P. — 10% owner 5AM Partners V, LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85 | EDGAR |
| 2026-08-03 | 4 | PARMAR KUSH — Director, 10% owner | Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85 | EDGAR |
| 2026-06-12 | 4 | Radhakrishnan Maha — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Chapman Gina — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Zeiher Bernhardt G — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | PARMAR KUSH — Director, 10% owner | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Thistle Mary — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | KIM PETER S — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Zeiher Bernhardt G — Director | Purchase (P): 5,000 @ $5.86 | EDGAR |
| 2026-05-04 | 4 | Sethuraman Natarajan — President, Research & Develop. | Sale (S): 25,907 @ $15.39 | EDGAR |
| 2026-05-04 | 4 | Dowden Nathan J — President & COO | Option exercise (M): 15,000 @ $1.74 · Sale (S): 15,000 @ $15.33 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Sale (S): 2,500 @ $12.95 | EDGAR |
| 2026-03-11 | 4 | Dowden Nathan J — President & COO | Sale (S): 3,116 @ $13.02 · Sale (S): 11,894 @ $13.05 | EDGAR |
| 2026-03-11 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Sale (S): 5,089 @ $13.00 · Sale (S): 11,388 @ $13.02 | EDGAR |
| 2026-03-06 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Sale (S): 7,988 @ $12.25 | EDGAR |
| 2026-03-03 | 4 | Sethuraman Natarajan — President, Research & Develop. | Grant/award (A): 55,800 @ $0 · Tax withholding (F): 3,898 @ $11.66 · Tax withholding (F): 7,577 @ $11.76 · Grant/award (A): 83,200 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Dowden Nathan J — President & COO | Grant/award (A): 55,800 @ $0 · Tax withholding (F): 7,223 @ $11.66 · Tax withholding (F): 14,038 @ $11.76 · Grant/award (A): 83,200 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Grant/award (A): 44,600 @ $0 · Tax withholding (F): 2,939 @ $11.66 · Tax withholding (F): 5,712 @ $11.76 · Grant/award (A): 66,600 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Doshi Dipal — CEO, Director | Grant/award (A): 139,400 @ $0 · Tax withholding (F): 9,869 @ $11.66 · Tax withholding (F): 19,181 @ $11.76 · Grant/award (A): 208,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Sale (S): 8,910 @ $9.98 | EDGAR |
| 2025-11-24 | 4 | BAKER BROS. ADVISORS LP — 10% owner Baker Bros. Advisors (GP) LLC — 10% owner BAKER FELIX — 10% owner BAKER JULIAN — 10% owner | Purchase (P): 1,213 @ $9.07 · Purchase (P): 13,386 @ $9.07 · Purchase (P): 1,186 @ $9.07 · Purchase (P): 13,082 @ $9.07 | EDGAR |
| 2025-11-18 | 4 | PARMAR KUSH — Director, 10% owner | Sale (S): 200,000 @ $8.80 | EDGAR |
| 2025-11-18 | 4 | 5AM Ventures V, L.P. — 10% owner 5AM Partners V, LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 200,000 @ $8.80 | EDGAR |
| 2025-11-12 | 4 | BAKER BROS. ADVISORS LP — 10% owner Baker Bros. Advisors (GP) LLC — 10% owner BAKER FELIX — 10% owner BAKER JULIAN — 10% owner | Purchase (P): 2,296 @ $7.21 · Purchase (P): 25,364 @ $7.21 · Purchase (P): 267 @ $7.22 · Purchase (P): 2,947 @ $7.22 · Purchase (P): 1,059 @ $7.39 · Purchase (P): 11,701 @ $7.39 · +6 more | EDGAR |
| 2025-09-04 | 4 | Sethuraman Natarajan — President, Research & Develop. | Tax withholding (F): 1,760 @ $5.43 | EDGAR |
| 2025-09-04 | 4 | Dowden Nathan J — President & COO | Tax withholding (F): 1,746 @ $5.43 | EDGAR |
| 2025-09-04 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Tax withholding (F): 1,734 @ $5.43 | EDGAR |
| 2025-09-04 | 4 | Doshi Dipal — CEO, Director | Tax withholding (F): 8,723 @ $5.43 | EDGAR |
| 2025-07-11 | 4 | PARMAR KUSH — Director, 10% owner | Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50 | EDGAR |
| 2025-07-11 | 4 | 5AM Ventures V, L.P. — 10% owner 5AM Partners V, LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50 | EDGAR |
| 2025-07-01 | 4 | PARMAR KUSH — Director, 10% owner | Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12 | EDGAR |
| 2025-07-01 | 4 | 5AM Ventures V, L.P. — 10% owner 5AM Partners V, LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner ROCKLAGE SCOTT M — 10% owner Schwab Andrew J. — 10% owner | Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12 | EDGAR |
| 2025-06-18 | 4/A | KIM PETER S — Director | Purchase (P): 25,000 @ $14.68 · Purchase (P): 25,000 @ $14.59 | EDGAR |
| 2025-06-12 | 4 | Zeiher Bernhardt G — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Chapman Gina — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | PARMAR KUSH — Director, 10% owner | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Thistle Mary — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | KIM PETER S — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Radhakrishnan Maha — Director | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-04-04 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Option exercise (M): 11,134 @ $2.10 · Option exercise (M): 11,134 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Sale (S): 1,784 @ $10.67 | EDGAR |
| 2025-03-04 | 4 | WENTWORTH KORY JAMES — Chief Financial Officer | Grant/award (A): 42,400 @ $0 · Tax withholding (F): 4,929 @ $11.68 · Grant/award (A): 63,300 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Dowden Nathan J — President & COO | Grant/award (A): 60,800 @ $0 · Tax withholding (F): 5,144 @ $11.68 · Grant/award (A): 90,800 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Sethuraman Natarajan — President, Research & Develop. | Grant/award (A): 60,800 @ $0 · Tax withholding (F): 6,138 @ $11.68 · Grant/award (A): 90,800 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Doshi Dipal — CEO, Director | Grant/award (A): 116,200 @ $0 · Tax withholding (F): 17,566 @ $11.68 · Grant/award (A): 173,400 (derivative) @ $0 | EDGAR |
Recent 8-K events — Entrada Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-06-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TRDA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →